The NT5C1A Antibody Test and Inclusion Body Myositis
On May 9, 2018, Dr. Kevin Dooley, a retired ophthalmologist who has the rare disease inclusion body myositis, joined us live for a patient-led video education session titled, “The NT5C1A Antibody Test and its Role in the Diagnosis of Inclusion Body Myositis.”
We provide you a recording of the live interactive session so you can learn more about the NT5CIA antibody and its association with inclusion body myositis.
Watch The NT5C1A Antibody Test and its Role in the Diagnosis of Inclusion Body Myositis
Kevin Dooley is the founder, Chairman, and author of Cure IBM.
Check out Cure IBM and support their efforts in inclusion body myositis education and research.